<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="65358">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01785238</url>
  </required_header>
  <id_info>
    <org_study_id>RC12_0238</org_study_id>
    <nct_id>NCT01785238</nct_id>
  </id_info>
  <brief_title>Nephronic Reduction After Neonatal Acute Renal Failure in Preterm</brief_title>
  <acronym>IRENEO</acronym>
  <official_title>Renal Prognosis of Former Preterm Infants 3 to 10 Years After Neonatal Acute Renal Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <authority>France:ANSM</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the signs of nephronic reduction in preterm infants who
      have presented neonatal acute renal failure. The investigators hypothesize that signs of
      nephronic reduction would appear earlier in former preterm with neonatal acute renal failure
      than in control preterm infants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      50 former preterm infants who presented acute renal failure will be evaluated between 3 to
      10 years.

      They will be compared to 25 control former preterm infants without renal dysfunction for
      signs of nephronic reduction.

      At inclusion, in order to analyse renal function, all infants will have blood sampling,
      renal echography and blood pressure measurement. Urine sample will also be collected.

      Two months later, parents will be informed on the results.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research</study_design>
  <primary_outcome>
    <measure>microalbuminuria</measure>
    <time_frame>Day 1 (at inclusion)</time_frame>
    <safety_issue>No</safety_issue>
    <description>The primary outcome of this study is to prove that former preterm infants with neonatal acute renal failure are at higher risk of nephronic reduction than control former preterm infants and that they will present microalbuminuria as earlier sign of nephronic reduction. Precisely, if microalbuminuria divided by creatinuria is above 20mg/g or 2mg/mmol, it will be considered as pathologic.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>measurement of blood pressure</measure>
    <time_frame>Day 1 (at inclusion)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evaluation of other renal parameters: blood pressure, renal filtration, tubular functions evaluation of renal size and differentiation by ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>measurement of length and volume of kidney by renal echography</measure>
    <time_frame>day 1</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>creatinine clearance</measure>
    <time_frame>day 1</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>calciuria</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sodium clearance</measure>
    <time_frame>day 1</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Neonatal Acute Renal Failure in Preterm</condition>
  <arm_group>
    <arm_group_label>cases with neonatal acute renal failure in preterm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>controls without neonatal acute renal failure in preterm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>renal echography</intervention_name>
    <description>renal echography to analyse the kidney</description>
    <arm_group_label>cases with neonatal acute renal failure in preterm</arm_group_label>
    <arm_group_label>controls without neonatal acute renal failure in preterm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood sampling</intervention_name>
    <description>Blood sampling to analyse different parameters of renal function</description>
    <arm_group_label>cases with neonatal acute renal failure in preterm</arm_group_label>
    <arm_group_label>controls without neonatal acute renal failure in preterm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>collection of an urine sample</intervention_name>
    <description>Collection of an urine sample to perform analysis of renal function parameters</description>
    <arm_group_label>cases with neonatal acute renal failure in preterm</arm_group_label>
    <arm_group_label>controls without neonatal acute renal failure in preterm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood pressure measurement</intervention_name>
    <arm_group_label>cases with neonatal acute renal failure in preterm</arm_group_label>
    <arm_group_label>controls without neonatal acute renal failure in preterm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  For both group of cases (50 infants having presented acute renal failure in preterm)
             AND group of control cases (25 infants without this) :former preterm infant born
             before 33 weeks of gestational age between january 2003 and june 2010 and
             hospitalized in the neonatal intensive care unit of Nantes University Hospital.

          -  Specific to cases: neonatal acute renal failure: serum creatinine&gt;130 micromol/l from
             the third day of life.

          -  Control cases: no such renal dysfunction

        Exclusion Criteria:

          -  no parental consent

          -  other causes of renal failure: congenital uropathy, congenital nephropathy

          -  congenital cardiopathy, polymalformative syndrome
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emma ALLAIN-LAUNAY, PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Nantes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emma ALLAIN-LAUNAY, PH</last_name>
    <email>emma.allainlaunay@chu-nantes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alexandra BRUEL, PH</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU of Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emma ALLAIN-LAUNAY, PH</last_name>
      <email>emma.allainlaunay@chu-nantes.fr</email>
    </contact>
    <contact_backup>
      <last_name>Alexandra BRUEL, PH</last_name>
    </contact_backup>
    <investigator>
      <last_name>Emma ALLAIN-LAUNAY, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexandra BRUEL, PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>February 6, 2013</lastchanged_date>
  <firstreceived_date>January 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>preterm infants</keyword>
  <keyword>acute renal failure</keyword>
  <keyword>nephronic reduction</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
